XML 73 R62.htm IDEA: XBRL DOCUMENT v3.25.3
Investments - MedicBeacon Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Jan. 17, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Jan. 18, 2025
Dec. 31, 2024
Schedule of Investments [Line Items]              
Gain on sale of investments       $ 5,200,000 $ 0    
MediBeacon Inc.              
Schedule of Investments [Line Items]              
Beneficial ownership percentage   44.70%   44.70%     45.90%
MediBeacon Inc. | Life Sciences              
Schedule of Investments [Line Items]              
Gain on sale of investments       $ 4,400,000      
Realized loss, equity issuance       5,900,000      
Equity method investment, interest       1,500,000      
Equity method investments   $ 0   0     $ 0
Cumulative unrecognized loss on equity method investments   18,200,000   18,200,000      
MediBeacon Inc. | Life Sciences | Huadong              
Schedule of Investments [Line Items]              
Convertible notes and accrued interest converted to stock, in process $ 7,500,000            
Beneficial ownership percentage 45.90%         44.70%  
Ownership percentage, fully diluted basis 40.10%         39.70%  
MediBeacon Inc. | Life Sciences | Convertible Debt              
Schedule of Investments [Line Items]              
Notes receivable, face amount $ 11,400,000            
Accrued interest receivable 1,500,000            
Convertible notes and accrued interest converted to stock $ 12,900,000            
MediBeacon Inc. | Notes Receivable | Life Sciences              
Schedule of Investments [Line Items]              
Accrued interest receivable   400,000   400,000     1,700,000
Notes receivable   500,000   500,000     $ 12,000,000
Interest income   $ 15,000 $ 300,000 $ 100,000 $ 1,000,000